Ads
related to: novartis kesimpta- Learning Tools for HCPs
Learn More About
VUMERITY® Through MOA Data.
- VUMERITY® Efficacy
Learn More About The Efficacy Of
VUMERITY® Across 2 Pivotal Trials.
- Clinical Trials Info
Explore Clinical Trials And Study
Information For Prescribers.
- E-Sign Start Form
Download a VUMERITY® Start
Form & Begin Prescribing Patients.
- Coverage & Access Info
View VUMERITY® Copay &
Insurance Coverage Information.
- Switching to VUMERITY®
Consider Another Option
For Your Patients With VUMERITY®.
- Learning Tools for HCPs
Search results
Novartis Says Relapsing Multiple Sclerosis Patients Remained Free From Disease Progression For Up...
Benzinga via Yahoo Finance· 1 year agoNovartis AG (NYSE: NVS) announced new long-term data from the ALITHIOS open-label extension study of...
Novartis (NVS) Q2 Earnings & Revenues Top, Guidance Raised
Zacks via Yahoo Finance· 10 months agoSwiss pharma giant Novartis AG NVS reported strong second-quarter 2023 results and shares are...
Novartis Stock Hits Record High On A Trio Of First-Quarter Drivers
Investor's Business Daily· 1 year agoNovartis stock jumped to a record high Tuesday after a trio of drugs — including blockbuster heart...
Novartis (NVS) Q3 Earnings Top, Revenues Miss Estimates
Zacks via Yahoo Finance· 2 years agoNovartis AG NVS reported mixed third-quarter results for 2022 and revised its guidance for the...
Novartis (NVS) Tops Q3 Earnings, Ups Operating Income View
Zacks via Yahoo Finance· 7 months agoSwiss pharma giant Novartis AG NVS reported strong sales from key drugs in third-quarter 2023 and...
Novartis Ag (NVS) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 month agoImage source: The Motley Fool. Novartis Ag (NYSE: NVS) Q1 2024 Earnings Call Apr 23, 2024, 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers...
Novartis (NVS) Key Drugs and Pipeline Progress Fuel Growth
Zacks via Yahoo Finance· 9 months agoNovartis NVS has had a good run so far in 2023 and has gained strong momentum in the last couple of...
Novartis sees brighter sales future as R&D revamp continues
BioPharma Dive via Yahoo Finance· 6 months agoDive Brief: Novartis expects sales to grow faster than anticipated over the next five years as...
Novartis (NVS) to Report Q1 Earnings: What to Expect?
Zacks via Yahoo Finance· 1 month agoNovartis AG NVS, a Swiss pharma giant, is scheduled to report first-quarter 2024 results on Apr 23....
Novartis (NVS) to Report Q4 Earnings: Is a Beat in Store?
Zacks via Yahoo Finance· 4 months agoSwiss pharma giant Novartis AG NVS is scheduled to post fourth-quarter 2023 results on Jan 31. The...
Ads
related to: novartis kesimpta